Bleeding and Volume Replacement Therapy J. Málek.

45
Bleeding and Volume Replacement Therapy J. Málek

Transcript of Bleeding and Volume Replacement Therapy J. Málek.

Page 1: Bleeding and Volume Replacement Therapy J. Málek.

Bleeding andVolume Replacement

TherapyJ. Málek

Page 2: Bleeding and Volume Replacement Therapy J. Málek.

Casualty treatment

• call for medical help

• vital functions

• control of major external bleeding

• general examination

• prevention of secondary injuries

• detailed examination

Page 3: Bleeding and Volume Replacement Therapy J. Málek.

Blood

• in adults 40-50 ml/kg, in children 50-60 ml/kg

• oxygen and CO2 transport

• water and mineral balance

• transport of metabolites

• transport of hormones

• immunity

Page 4: Bleeding and Volume Replacement Therapy J. Málek.

Blood

• red cells

• white cells

• thrombocytes

• plasma

Page 5: Bleeding and Volume Replacement Therapy J. Málek.

Bleeding

• arterial, venous, capillary, mixed

• minor, major

• localisation

• normal, abnormal

Page 6: Bleeding and Volume Replacement Therapy J. Málek.

Minor bleeding

• clean with water

• apply antiseptic around the wound

• apply sterile dressing

Page 7: Bleeding and Volume Replacement Therapy J. Málek.
Page 8: Bleeding and Volume Replacement Therapy J. Málek.

Bleeding

• external

• internal

• from body orifices

• mixed

Page 9: Bleeding and Volume Replacement Therapy J. Málek.

Major external bleeding• lay the victim down to supine position• compress and elevate the bleeding site (if

possible)– pressure dressing– manual compression– pressure points– tourniquet

• do not try to clean a large wound (remove only obvious debris)

• never remove a foreign body

Page 10: Bleeding and Volume Replacement Therapy J. Málek.
Page 11: Bleeding and Volume Replacement Therapy J. Málek.
Page 12: Bleeding and Volume Replacement Therapy J. Málek.
Page 13: Bleeding and Volume Replacement Therapy J. Málek.

Internal bleeding

• pain

• signs of injury

• signs of shock

Page 14: Bleeding and Volume Replacement Therapy J. Málek.

Internal bleeding

• positioning

• call for emergency

• nothing per os

Page 15: Bleeding and Volume Replacement Therapy J. Málek.

Bleeding from body orifices

• mouth

• nose

• ear

• haemoptoea

• vomiting of blood

• rectal bleeding/melaena

• vaginal bleeding

Page 16: Bleeding and Volume Replacement Therapy J. Málek.

Volume replacement therapy

• crystalloid solutions

• colloids solutions– volume substituents– volume expanders

• blood

Page 17: Bleeding and Volume Replacement Therapy J. Málek.

Crystalloid solutions

• advantages• no allergic reactions• easily available• low effect on blood

coagulation• easily mobilised

• disadvantages• move quickly from

blood vessels• no transport capacity

for oxygen

Page 18: Bleeding and Volume Replacement Therapy J. Málek.

Colloid solutions

• dextrans

• gelatine

• starch

Page 19: Bleeding and Volume Replacement Therapy J. Málek.

Colloid solutions

• advantages• stay longer in blood

vessels• rapid volume

replacement (molecular weight dependent)

• easily available

• disadvantages• allergic reaction

possible• various effect on blood

coagulation• difficulty in

mobilisation• no transport capacity

for oxygen

Page 20: Bleeding and Volume Replacement Therapy J. Málek.

Blood and blood products

• packed red cells

• fresh frozen plasma

• thrombocytes

• various factors

Page 21: Bleeding and Volume Replacement Therapy J. Málek.

Risks of blood transfusion

• incompatibility

• infection

• allergy

• fever

• overloading

• bleeding problems

• immunity

Page 22: Bleeding and Volume Replacement Therapy J. Málek.

Blood transfusion

• indication

• patient´s consent

• taking blood sample to transfusion dept.

• cross match in TD

• check documentation and transfusion bag

• security test

• biological test

Page 23: Bleeding and Volume Replacement Therapy J. Málek.

Blood groups

Page 24: Bleeding and Volume Replacement Therapy J. Málek.

Population     O+      

A+      

B+      

AB+      

O−      

A−      

B−      

AB−      

Argentina[11] 53.8% 34.7% 8.8% 2.7% 8.4% 0.44% 0.21% 0.06%

Australia[12] 40% 31% 8% 2% 9% 7% 2% 1%

Belgium[13] 38.1% 34% 8.5% 4.1% 7% 6% 1.5% 0.8%

Canada[14] 39% 36% 7.6% 2.5% 7% 7% 1.4% 0.5%

Denmark[15] 35% 37% 8% 4% 6% 7% 2% 1%

Finland[16] 27% 38% 15% 7% 4% 6% 2% 1%

France[17] 36% 37% 9% 3% 6% 7% 1% 1%

Hong Kong, China[18]

40% 26% 27% 7% <0.3% <0.3% <0.3% <0.3%

Korea, South[19] 27.4% 34.4% 26.8% 11.2% 0.1% 0.1% 0.1% 0.05%

Netherlands[20] 39.5% 35% 6.7% 2.5% 7.5% 7% 1.3% 0.5%

Poland[21] 31% 32% 15% 7% 6% 6% 2% 1%

Sweden[22] 32% 37% 10% 5% 6% 7% 2% 1%

UK[23] 37% 35% 8% 3% 7% 6% 2% 1%

USA[24] 38% 34% 9% 3% 7% 6% 2% 1%

Page 25: Bleeding and Volume Replacement Therapy J. Málek.

Human red blood cells before (left) and after (right) adding serum containing anti-A antibodies. The agglutination reaction reveals the presence of the A antigen on the surface of the cells.

                                                                            

Page 26: Bleeding and Volume Replacement Therapy J. Málek.
Page 27: Bleeding and Volume Replacement Therapy J. Málek.

Transfusion

• Colecting blood sample from the patient• Transfusion station

– Blood group– Crossmatching– Delivery

• Ward– Check delivery list– Safety test– Biological test– Monitoring – Save blood pack for 24 hours

Page 28: Bleeding and Volume Replacement Therapy J. Málek.

Indications for blood transfusions

• acute hemorrhage

• anemia

• bleeding disorders

• hematological diseases

Page 29: Bleeding and Volume Replacement Therapy J. Málek.

Acute bleeding

Blood loss Replacement

<750 ml crystalloid solutions

750 – 1500 ml crystalloid solutions (colloid solutions or blood)

>1500 ml crystalloid solutions (colloid solutions) + blood

Page 30: Bleeding and Volume Replacement Therapy J. Málek.

Shock

Page 31: Bleeding and Volume Replacement Therapy J. Málek.

Definition

Acute state in which tissue perfusion is inadequate to maintain the supply of oxygen and nutritients necessary for normal cell function, which results in widespread hypoxia.

Page 32: Bleeding and Volume Replacement Therapy J. Málek.

Reasons for inadequate tissue perfusion

• A decreased circulating blood volume – hypovolaemic shock

• A failure of the heart to pump effectively – cardiogenic shock and obstructive shock

• A massive increase in peripheral vasodilatation – neurogenic shock

• Combination – septic shock, anaphylactic shock

Page 33: Bleeding and Volume Replacement Therapy J. Málek.

Stages of shock

• Initial stage – anaerobic metabolism

• Compensatory stage – centralisation of circulation

• Progressive stage – increased acidosis, leakage of fluid from the capillaries and formation of microthrombes

• Refractory stage

Page 34: Bleeding and Volume Replacement Therapy J. Málek.

Classification of shock

• Hypovolaemic shock

• Cardiogenic shock

• Anaphylactic shock

• Septic shock

• Neurogenic shock

Page 35: Bleeding and Volume Replacement Therapy J. Málek.

Hypovolaemic shock

• Haemorrhage

• Plasma loss

• Extracelular fluid loss

Page 36: Bleeding and Volume Replacement Therapy J. Málek.

Symptoms of hypovolemia according to blood loss

Blood loss (ml) Symptoms

<750 none

-1 500 thirst, weakness, tachypnoea

-2 000 systolic pressure falls

>2 000 no pulse on periphery

Page 37: Bleeding and Volume Replacement Therapy J. Málek.

Estimated blood loss in trauma

Pelvis 3 000 mL

Femur 1 000 mL

Tibia 650 mL

Abdominal injury 2 000 – 4 000 mL

Thoracic injury 2 000 – 4 000 mL

Page 38: Bleeding and Volume Replacement Therapy J. Málek.
Page 39: Bleeding and Volume Replacement Therapy J. Málek.

Signs of haemorrhagic shock

• Pale, cold, clammy skin, decreased capilary refill

• Rapid, weak and thready pulse

• Thirst

• Decreased urine production

• Increased respiratory rate

• Change in mental status – late sign

Page 40: Bleeding and Volume Replacement Therapy J. Málek.

First aid• Prevent further blood loss

• Antishock or autotransfusion position

• Activation of emergency service

• Prevention of hypothermia

• Prevention of positioning trauma

• Treatment of other injuries, immobilisation of fractures

• Nil by mouth, no oral or i.m. medication

Page 41: Bleeding and Volume Replacement Therapy J. Málek.

Medical treatment

• Intravenous access

• Surgery

• Fluid replacement

• Artificial ventilation

• Pharmacological support of shock organs

• Monitoring: BP, P, SaO2, CPV, urine output

Page 42: Bleeding and Volume Replacement Therapy J. Málek.

Cardiogenic shock

• Heart failure, cardiomyopathy

• Decreased cardiac output

• First vasoconstriction, next vasodilatation due to acidosis

• Pulmonary oedema

• Cold, clammy and cyanotic skin

• Mortality 80 per cent

Page 43: Bleeding and Volume Replacement Therapy J. Málek.

Anaphylactic shock

• Severe allergic reaction

• Degranulation of mast cells

• Vasodilatation, increased vascular permeability, oedema, bronchospasm

Page 44: Bleeding and Volume Replacement Therapy J. Málek.

Septic shock

• Bacteria or bacterial toxins

• Released histamine and other mediators of inflammation

• Oxygen demand – supply mismatch

• Vasodilatation

• Tachycardia, hypotension, fever of hypothermia

Page 45: Bleeding and Volume Replacement Therapy J. Málek.

Neurogenic (spinal) shock

• Loss of sympathetic nerve activity

• Massive vasodilatation